ClinicalTrials.Veeva

Menu

Smoking Cessation Study

McGill University logo

McGill University

Status

Enrolling

Conditions

Smoking Cessation
Arthropathy

Treatments

Behavioral: Lifestyle Counseling

Study type

Observational

Funder types

Other

Identifiers

NCT05602753
2020-6424

Details and patient eligibility

About

The primary outcome of this study is to determine the true incidence of smokers among patients undergoing joint replacement and secondly, what percent are able to quit smoking before surgery under a structured cessation program with carbon monoxide breath testing. The investigators hypothesize that self-reported smoking status is underreported and that routine carbon monoxide breath testing will improve abstinence rates at the time of surgery.

Full description

This study looks at patients who have been referred to our clinic for a potential hip and knee joint replacement surgery. Once it has been determined that the patient requires surgical replacement of either their hip or knee and is placed on our surgical waitlist, the patient will be asked if he or she would like to participate in the study. The investigators would ask all patients, both self-declared smokers and non-smokers, to participate. This study would include completing a smoking history questionnaire and a noninvasive carbon monoxide breath test. While smoking status is already assessed in the McGill University Health Centre preoperative questionnaire, the investigators intend on expanding these questions in study participants to better quantify their nicotine exposure.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ages 18-85 who require a primary total hip or knee replacement
  • Any gender
  • Smokers and non-smokers
  • Osteoarthritis, rheumatoid arthritis, avascular necrosis

Exclusion criteria

  • Patients who require revision surgery
  • Previous fracture to affected area
  • Emergency surgery
  • Patients who do not understand, read or communicate in either French or English

Trial design

300 participants in 3 patient groups

Smokers
Description:
All patients who participate in the study will complete the smoking history questionnaire and the carbon monoxide breath test. All patients with positive carbon monoxide breath test indicative of active nicotine exposure will be provided a structured smoking cessation program that includes information, counseling from their surgeon, or a trained health care professional and referral to a smoking cessation program.
Treatment:
Behavioral: Lifestyle Counseling
Non-Smokers
Description:
Subjects who self-declared as non-smokers
Declared non-smokers with elevated Co2
Description:
subjects who self-declared as non-smokers but who tested positive for elevated Co2,

Trial contacts and locations

1

Loading...

Central trial contact

Adam Hart, MD; Karen Smith, CRA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems